{"result": "(\"entity\"<|>BURN PATIENTS<|>PERSON<|>Burn patients are individuals who have suffered from burns and may require specialized nutritional support during recovery.)\n##\n(\"entity\"<|>CANCER PATIENTS<|>PERSON<|>Cancer patients are individuals undergoing treatment for cancer, often requiring specific nutritional interventions to support their health.)\n##\n(\"entity\"<|>IMMUNONUTRITION<|>EVENT<|>Immunonutrition refers to the use of specialized nutritional formulas designed to enhance immune function, particularly in patients undergoing surgery or suffering from malnutrition.)\n##\n(\"entity\"<|>NUTRITIONAL SUPPORT<|>EVENT<|>Nutritional support encompasses various interventions aimed at providing adequate nutrition to patients, especially those with specific medical conditions.)\n##\n(\"entity\"<|>SEPSIS<|>EVENT<|>Sepsis is a severe medical condition resulting from an infection that can lead to systemic inflammation and organ failure, often requiring intensive care and nutritional support.)\n##\n(\"entity\"<|>GASTROENTEROLOGY<|>ORGANIZATION<|>Gastroenterology is a medical specialty focused on the digestive system and its disorders, often involved in the nutritional management of patients.)\n##\n(\"entity\"<|>NUTRIENTS<|>ORGANIZATION<|>Nutrients are substances that provide nourishment essential for the maintenance of life and for growth, often discussed in the context of patient care.)\n##\n(\"relationship\"<|>BURN PATIENTS<|>IMMUNONUTRITION<|>Burn patients often benefit from immunonutrition to enhance recovery and reduce complications<|>8)\n##\n(\"relationship\"<|>CANCER PATIENTS<|>IMMUNONUTRITION<|>Cancer patients may require immunonutrition to support their immune system during treatment<|>8)\n##\n(\"relationship\"<|>BURN PATIENTS<|>NUTRITIONAL SUPPORT<|>Burn patients require specialized nutritional support to aid in their recovery<|>9)\n##\n(\"relationship\"<|>CANCER PATIENTS<|>NUTRITIONAL SUPPORT<|>Cancer patients often need nutritional support to manage treatment side effects and improve outcomes<|>9)\n##\n(\"relationship\"<|>SEPSIS<|>NUTRITIONAL SUPPORT<|>Patients with sepsis may require nutritional support to help manage their condition and improve recovery<|>7)\n##\n(\"relationship\"<|>GASTROENTEROLOGY<|>NUTRITIONAL SUPPORT<|>Gastroenterology specialists often provide nutritional support for patients with digestive disorders<|>6)\n##\n(\"relationship\"<|>NUTRIENTS<|>IMMUNONUTRITION<|>Nutrients are critical components of immunonutrition formulas designed to enhance immune function<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: enteral de pacientes quemados y con traumatismos. Grado A.\n- Se deben utilizar fórmulas inmunomoduladoras en pacientes sometidos a cirugía de cáncer de cuello. Grado A.\n- Se deben utilizar fórmulas inmunomoduladoras en pacientes sometidos a cirugía de cáncer de abdomen. Grado A.\n- No se pueden hacer recomendaciones directas para los pacientes quemados por la existencia de datos insuficientes.\n\nNo obstante, nos encontramos ante una de las áreas de conocimiento en soporte nutricional que más interés genera, siendo frecuentes los posicionamientos de sociedades científicas o revisiones/análisis de la literatura53. De este modo, en una reciente revisión sistemática de la literatura en pacientes con cirugía electiva de patología tumoral de tubo digestivo alto se demuestran claros beneficios coste-efectivos con el uso de estas fórmulas al disminuir las infecciones postoperatorias y la estancia hospitalaria54, estimándose unos ahorros por paciente de 3 300 dólares por infecciones y 6 000 dólares por estancias55. Por último, existen áreas, en las cuales la investigación es escasa, como por ejemplo la cirugía oncológica a nivel ginecológico56, o patologías como la pancreatitis aguda, en la que algún ensayo clínico aleatorizado ha mostrado beneficio en la estancia hospitalaria y complicaciones infecciosas con inmunonutrientes en nutrición parenteral57.\n\n## 6. Bibliografía\n\n1. Słotwiński R, Sarnecka A, Dąbrowska A, Kosałka K, Wachowska E, Bałan BJ, Jankowska M, Korta T, Niewiński G, Kański A, Mikaszewska-Sokolewicz M, Omidi M, Majewska K, Słotwińska SM Innate immunity gene expression changes in critically ill patients with sepsis and disease-relatedmalnutrition. Cent Eur J Immunol. 2015; 40:311-24.\n\n2. González-Torres C, González-Martínez H, Miliar A, Nájera O, Graniel J, Firo V, Alvarez C, Bonilla E, Rodríguez L. Effect of malnutrition on the expression of cytokines involved in Th1 cell differentiation. Nutrients. 2013; 5:579-93.\n\n3. Grimble RF. Immunonutrition. Current opinion of gastroenterology 2005; 21:216-222.\n\n4. DA de luis, R Aller, Oizaola, L Cuellar, MC Terroba. Enteral immunonutrition (w3 enhanced formula vs arginine enhanced formula) in head and neck cancer ambulatory patients. Ann Nutr Med 2005; 49:95-99.\n\n5. Scalise M, Pochini L, Galluccio M, Indiveri C. Glutamine transport. From energy supply to sensing and beyond. Biochim Biophys Acta. 2016 Mar 4. pii: S0005-2728(16)30052-4.\n\n6. Basu NH, Liepa GU. Arginine: a clinical perspective. Nutr Clin Pract 2002; 17:218-25.\n\n7. Feihl F, Waeber B. Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmcaol Ther 2001; 91:179-213.\n\n8. Gottschlich MM, Jenkins M, Warden GD, Baumer T, Havens P, Snook JT, Alexander JW. Differential effects of three enteral dietary regimens on selected outcome variables in burn patients. JPEN 1990; 14:225-236.\n\n9. Saffle JR, Wiebke G, Jennings K, Morris SE, Barton RG. Randomized trial of immune-enhacing enteral nutrition in burn patients. J Trauma 1997; 42:793-800.\n\n10. Berger MM, Spertini F, Shenkin A. Trace element supplementation modulates pulmonary infection rates after major burns: a double blind placebo controlled trial. Am J Clin Nutr 1998; 68:365-371.\n\n11. Chuntrasakul C1, Siltham S, Sarasombath S, Sittapairochana C, Leowattana W, Chockvivatanavanit S, Bunnak A Comparison of a immunonutrition formula enriched arginine, glutamine and omega-3 fatty acid, with a currently high-enriched enteral nutrition for trauma patients J Med Assoc Thai. 2003 Jun; 86(6):552-61.\n\n12. Tan HB, Danilla S, Murray A, Serra R, El Dib R, Henderson TO, Wasiak J. Immunonutrition as an adjuvant therapy for burns. Cochrane Database Syst Rev. 2014; 12:CD007174. doi: 10.1002/14651858. CD007174.pub2. Epub 2014 Dec 23.\n\n13. Brown RO, Hunt H, Mowatt-Larssen CA, Wojtysiak SL, Henningfield MF, Kudsk KA. Comparison of specialized and standard enteral formulas in trauma\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}